info@synchemia.com | sales@synchemia.com 
9766925136 | 72 
N-Nitroso Enzalutamide Impurity 1
.png)
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Enzalutamide is used to treat castration-resistant prostate cancer (prostate cancer that is resistant to medical or surgical treatments that lower testosterone), and metastatic castration-sensitive prostate cancer (prostate cancer that has spread to other parts of the body and responds to a hormone therapy or surgical.N-Nitroso Enzalutamide Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Enzalutamide Impurity 1 CAS NO:NA chemically represented as N-(4-Cyano-3-(trifluoromethyl)phenyl)nitrous amide. Synchemia is the leading manufacturing and exporter of N-Nitroso Enzalutamide Impurity 1.We supply N-Nitroso Enzalutamide Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Related Products
| CAT No | SRC-N0142243 |
| CAS No | NA |
| Mol.F. | C11H9N3O2 |
| Mol.Wt. | 215.21g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142244 |
| CAS No | NA |
| Mol.F. | C16H15N5O2 |
| Mol.Wt. | 309.33 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142245 |
| CAS No | NA |
| Mol.F. | C28H31N5O4 |
| Mol.Wt. | 501.59 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142246 |
| CAS No | NA |
| Mol.F. | C24H23ClN4O4 |
| Mol.Wt. | 466.92 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142247 |
| CAS No | NA |
| Mol.F. | C26H27ClN4O4 |
| Mol.Wt. | 494.98 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142248 |
| CAS No | NA |
| Mol.F. | C28H31N5O5 |
| Mol.Wt. | 517.59 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142249 |
| CAS No | NA |
| Mol.F. | C11H13ClN4O5S3 |
| Mol.Wt. | 412.89 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142250 |
| CAS No | NA |
| Mol.F. | C18H28N2O |
| Mol.Wt. | 288.44 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142251 |
| CAS No | NA |
| Mol.F. | C24H30N2O8 |
| Mol.Wt. | 474.51 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142252 |
| CAS No | NA |
| Mol.F. | C18H22N2O2 |
| Mol.Wt. | 298.39 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142253 |
| CAS No | NA |
| Mol.F. | C16H22N2O2 |
| Mol.Wt. | 274.36 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142254 |
| CAS No | NA |
| Mol.F. | C13H17BrN2O2 |
| Mol.Wt. | 313.2 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0142255 |
| CAS No | NA |
| Mol.F. | C14H17Br2N3O2 |
| Mol.Wt. | 419.12 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142256 |
| CAS No | NA |
| Mol.F. | C13H17Br2N3O2 |
| Mol.Wt. | 407.11 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142257 |
| CAS No | NA |
| Mol.F. | C13H18BrN3O2 |
| Mol.Wt. | 328.21 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142258 |
| CAS No | NA |
| Mol.F. | C13H15Br2N3O2 |
| Mol.Wt. | 405.09 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
